DR.PLINUS ZERO TROUBLE

Manufacturer
S Skin Co., Ltd. | BIOCOSONE CO.,LTD
Effective date
2022-10-18
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:51:24

Label at a glance#

ProductDR.PLINUS ZERO TROUBLE
Active ingredientGLUCONOLACTONE, EPIGALLOCATECHIN GALLATYL GLUCOSIDE, Madecassoside
Label structure10 sections

Indications and uses

■ Helps with exfoliation ■ Helps sebum control ■ Helps to soothe your skin

Dosage and administration

① Before using the patch, wash your face. ② Open the pouch and take the patches out from the clear case, and remove the protective films on patch (* one by one. At this point, be careful not to touch the middle part of the patch.) ③ Adjust the patches on your face where you concern and press lightly at a right angle. ④ Attach the patch above at least 60 minutes.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Gluconolactone 2.14%
Epigallocatechin Gallatyl Glucoside 0.05%
Madecassoside 0.0013%(13ppm)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Sodium Hyaluronate, Water, Butylene Glycol, Niacinamide, Ectoin, 1.2-Hexanediol, Centella Asiatica Extract

PURPOSE

OTC - PURPOSE SECTION

Exfoliation
Sebum control
Calming

WARNINGS

WARNINGS SECTION

1. Discontinue to use or consult with dermatologist if irritation, swelling or itching appears after applying the product
2. Avoid applying patches on the wounded, dermatitis, and inflamed skin parts
3. Safety and storage precautions
A) Keep out of children's reach
B) Keep away from direct sunlight
C) Use immediately after opening
D) Do not reuse the patch you have already attached once
E) For external use only

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of children's reach

Uses

INDICATIONS & USAGE SECTION

■ Helps with exfoliation
■ Helps sebum control
■ Helps to soothe your skin

Directions

DOSAGE & ADMINISTRATION SECTION

① Before using the patch, wash your face.
② Open the pouch and take the patches out from the clear case, and remove the protective films on patch
(* one by one. At this point, be careful not to touch the middle part of the patch.)
③ Adjust the patches on your face where you concern and press lightly at a right angle.
④ Attach the patch above at least 60 minutes.

Other Information

OTHER SAFETY INFORMATION

■ Do not store this product in an inappropriate place such as high or low temperatures or under direct sun light

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of containerImage of container

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72630-030-022022-10-14C16284748780-1e4f33bdf-9b87-d8a0-e053-dadaa90a6e4eca117510-27f2-4344-8241-fdb564de1901
72630-030-022022-07-29C16284748780-1e4f33bdf-9b87-d8a0-e053-dadaa90a6e4eca117510-27f2-4344-8241-fdb564de1901

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72630-03072630-030-01, 72630-030-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
21abf368-870e-d806-e063-6394a90add49ca117510-27f2-4344-8241-fdb564de19012024-09-09WarningsExact identifier
spl set id: ca117510-27f2-4344-8241-fdb564de1901

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.